The field of immuno-oncology focuses on the immune system’s role in recognizing, targeting, and eliminating cancer cells. Tumor-specific immune responses offer a pathway for precisely targeting cancer cells while sparing healthy tissue, potentially providing long-term protection against recurrence through immune memory.

The 12th Immuno-Oncology Summit 2024 was held in Philadelphia, PA on August 7-9, 2024. The annual event serves as a vital platform for exchanging high-quality research and fostering collaboration in the ever-evolving landscape of immuno-oncology.

The 7th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference 2024 was held in Boston, MA on 20-21 June, 2024. The event brought together academics and scientists from research institutes and biopharmaceutical companies to discuss the latest updates, challenges, and future directions in immuno-oncology research.